Further analyses demonstrated that other immune checkpoint markers such as CD274 (PD1), CTLA4, or HAVCR2 (TIM3) were not differentially expressed within SCLC-A tumors when stratified by DDR status (Supplementary Fig. 12). Here, CTLA4 is linked to small cell lung carcinoma.